Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Colon Cancer

Thank you

Trial Information


Inclusion Criteria:



- Subjects must be 18 years of age or older.

- Subjects must be AA or Caucasian.

- Subjects with pathologic stage II colon cancer; Irrespective of number of nodes
examined.

Exclusion Criteria:

- Patients of races other than AA or Caucasian.

- No tumor block available from initial diagnosis.

- No tumor or very little tumor (<5% tumor present) in block as assessed by examination
of the H&E slide by the GHI-designated pathologist.

- Tumor types other than adenocarcinoma NOS and mucinous carcinoma as assessed by
examination of the H&E slide by the GHI-designated pathologist.

- Insufficient RNA (<5 ng/μL or 300 ng) for RT-PCR analysis.

- Failure of assay to meet pre-specified quality control (QC) specifications.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Compare the prognosis of colon cancer patients compared to gene expression.

Outcome Description:

Compare the values of the Recurrence Score and expression levels of gene groups and individual genes between African Americans and Caucasians with Stage II colon cancer

Outcome Time Frame:

1 year

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

133972

NCT ID:

NCT01479894

Start Date:

November 2011

Completion Date:

Related Keywords:

  • Colon Cancer
  • Colonic Neoplasms

Name

Location

University of Arkansas for Medical SciencesLittle Rock, Arkansas  72205